VERA — Vera Therapeutics, Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Vera Therapeutics,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -32.6 | -89.1 | -96 | -152 | -300 |
| Depreciation | |||||
| Non-Cash Items | 5.21 | 14.7 | 9.68 | 14.7 | 35.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.51 | 6.75 | -5.87 | 2.66 | 23 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -23.7 | -67.6 | -92.2 | -135 | -241 |
| Capital Expenditures | -5 | -0.062 | -0.063 | -0.972 | -0.63 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.796 | -70.5 | -39.4 | -424 | 195 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.2 | -70.6 | -39.4 | -425 | 194 |
| Financing Cash Flow Items | -2.77 | -6.1 | -7.26 | -39.3 | -21.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 53.9 | 102 | 134 | 607 | 309 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 26 | -36.2 | 1.93 | 47 | 262 |